IPSWICH, MA (May 10th, 2021) — New England Biolabs, Inc. (NEB®), a leading supplier of life science reagents, today announces that it has entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB.

With the point-of-care market becoming more focused on the development of robust, accurate and cost-effective diagnostic tests for use outside of traditional hospital and laboratory settings, there is a growing need for reagents that can withstand ambient shipping and storage. Lyophilization is the preferred solution and is a well-established technology across a number of industries, making it desirable from a regulatory and feasibility perspective. NEB currently supplies research use only reagents for further development and validation by its customers in diagnostic assays, and is looking to increase its ability to offer lyophilized reagents.

Read the full Press Release: https://international.neb.com/about-neb/news-and-press-releases/new-england-biolabs-to-acquire-fluorogenics-limited